Earlier in March, the Chinese NMPA issued new regulations for API DMFs in China. Now, DMF manufacturers need to pay the NMPA about $50,000 to get their APIs activated in China whereas there used to be no government fee. Also, more documents are needed. The following documents and samples are required... Read More
Medical institutions in Shanghai that provide online diagnosis and treatment during the COVID-19 outbreak will now be eligible for reimbursement by China’s national health insurance authority. Under a pilot program, services to be covered include online follow-up consultations for common and chronic... Read More
With U.S. medical personnel and institutions facing key supply shortages in fighting the COVID-19 virus outbreak, trade officials in March removed tariffs on dozens of medical items imported from China. The tariff exemptions on face masks, exam gloves, surgical drapes, protective gowns,... Read More
More cancer patients are being diagnosed in China than in any other global market in the world. Cancer is rampant in China due to a number of factors including an aging population, smoking, air pollution, as well as other poor lifestyle choices.... Read More
As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
This article was originally published on MedTech Intelligence. The use of artificial intelligence in healthcare is accelerating rapidly, as devices and products that mimic human learning and behavior are on track to get regulatory approval in the United States, Europe and increasingly,... Read More
The coronavirus will affect the medical supply chain coming from China. Various reports indicate that while 50% of Chinese factories are now open, only about half of these are actually producing medical products. Many Chinese employees are still working from home. While... Read More
As China pushes ahead with its policy of extracting price cuts from pharmaceutical manufacturers in exchange for access to its vast market, it is increasingly putting pressure on the profit margins of foreign and domestic drug manufacturers. Some drug firms are finding... Read More
For the first time, China on January 1 began regulating the use of customized medical devices, which are similar to already-approved devices, but custom-made to the specifications of a single patient based on prescribed needs. Until now, customized medical devices, often made... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More